House Publications
The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Publication Selector by Date
Dates with dots provide a link to available publications.
To access Debates and Journals from 1867 to 1993, please visit the Canadian Parliamentary Historical Resources portal.
To access Debates and Journals from 1867 to 1993, please visit the Canadian Parliamentary Historical Resources portal.
43rd Parliament ,2nd Session
(September 23, 2020 - August 15, 2021)
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Retrieving Calendars...
Status of House Business
Cumulative information on the status of business before the House, updated after each sitting.
|
|
|
|
Wednesday, February 17, 2021 (No. 60)
|
|
|
|
Notices of Motions for the Production of Papers |
Avis de motions portant production de documents |
| P-2 — February 1, 2021 — Ms. Rempel Garner (Calgary Nose Hill) — That an order of the House do issue for a copy of all unredacted contracts, or purchase agreements, between the government and Pfizer regarding the procurement of the vaccine manufactured by Pfizer for immunization against the SARS-CoV2 virus, commonly known as COVID-19. | P-2 — 1er février 2021 — Mme Rempel Garner (Calgary Nose Hill) — Qu'un ordre de la Chambre soit donné en vue de la production de tous les contrats, ou ententes d'achat, en texte intégral entre le gouvernement et Pfizer au sujet de l’acquisition du vaccin fabriqué par Pfizer pour l’immunisation contre le virus SARS-CoV2, communément appelé COVID-19. |